Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TUCIDINOSTAT: 251 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
251
Total FAERS Reports
63 (25.1%)
Deaths Reported
58
Hospitalizations
251
As Primary/Secondary Suspect
32
Life-Threatening

First Report: 20150822 · Latest Report: 20250908

What Are the Most Common TUCIDINOSTAT Side Effects?

#1 Most Reported
Myelosuppression
85 reports (33.9%)
#2 Most Reported
Disease progression
37 reports (14.7%)
#3 Most Reported
Anaemia
33 reports (13.1%)

All TUCIDINOSTAT Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 85 33.9% 4 24
Disease progression 37 14.7% 19 3
Anaemia 33 13.2% 5 4
Pneumonia 30 12.0% 13 5
Off label use 28 11.2% 7 10
Platelet count decreased 24 9.6% 3 11
Nausea 22 8.8% 5 3
White blood cell count decreased 21 8.4% 1 8
Drug ineffective 19 7.6% 8 2
Treatment failure 16 6.4% 12 4
Neutrophil count decreased 15 6.0% 0 4
Thrombocytopenia 15 6.0% 4 3
Febrile neutropenia 13 5.2% 2 0
Pyrexia 13 5.2% 1 5
Hypokalaemia 12 4.8% 1 4
Neutropenia 12 4.8% 3 1
Lymphocyte count decreased 11 4.4% 2 4
Therapy partial responder 11 4.4% 3 2
Diarrhoea 10 4.0% 1 2
Infection 10 4.0% 5 2

Who Reports TUCIDINOSTAT Side Effects? Age & Gender Data

Gender: 47.8% female, 52.2% male. Average age: 53.7 years. Most reports from: CN. View detailed demographics →

Is TUCIDINOSTAT Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 4 0 4
2016 1 0 1
2017 3 1 2
2019 6 1 5
2020 1 0 1
2021 3 1 1
2022 9 2 2
2023 19 3 9
2024 25 3 14
2025 9 0 5

View full timeline →

What Is TUCIDINOSTAT Used For?

IndicationReports
Diffuse large b-cell lymphoma 63
Acute myeloid leukaemia 39
Peripheral t-cell lymphoma unspecified 17
Diffuse large b-cell lymphoma refractory 14
Chemotherapy 12
Angioimmunoblastic t-cell lymphoma 7
Plasma cell myeloma 7
T-cell lymphoma 6
Acute myeloid leukaemia refractory 5
Cutaneous t-cell lymphoma 5

TUCIDINOSTAT vs Alternatives: Which Is Safer?

TUCIDINOSTAT vs TYKERB TUCIDINOSTAT vs TYLENOL TUCIDINOSTAT vs TYROTHRICIN TUCIDINOSTAT vs TYSABRI TUCIDINOSTAT vs TYVASO TUCIDINOSTAT vs UBIDECARENONE TUCIDINOSTAT vs UBLITUXIMAB TUCIDINOSTAT vs UBLITUXIMAB-XIIY TUCIDINOSTAT vs UBROGEPANT TUCIDINOSTAT vs ULIPRISTAL

Official FDA Label for TUCIDINOSTAT

Official prescribing information from the FDA-approved drug label.